Changes in the immunohistochemical localisation of fibroblast growth factor-2, transforming growth factor-beta 1 and thrombospondin-1 are associated with early angiogenic events in the hyperplastic rat thyroid.
Administration of a goitrogen (methimazole) and a low iodine diet to rats over a two-week period resulted in hypothyroidism and thyroid hyperplasia compared with controls (control: total serum thyroxine (T4) 66 +/- 4 nmol/l, thyroid weight 5 +/- 1 mg/100 g body weight; experimental: T4 undetectable, thyroid weight 27 +/- 4 mg/100 g body weight after 2 weeks of treatment; mean +/- S.D., n = 10). Immunohistochemistry carried out using a specific endothelial cell marker, CD31, and morphometric analysis (point counting of immunopositive cells) revealed that the progression of goitre in the rat thyroid is accompanied by an increase in capillary endothelial cell growth (neovascularisation). Fibroblast growth factor-2 (FGF-2) immunohistochemistry revealed widespread staining for the protein in the follicular cells of control glands. Less intense staining was found in the stroma and follicular cell nuclei. During hyperplasia and subsequent neovascularisation there was a progressive increase in the FGF-2 immunoreactivity at all locations during the two-week treatment period. Thrombospondin-1 (TSP1) immunoreactivity in the control rat thyroid was found in the stroma and in the endothelial cells, while weak follicular cell staining was also present. In the goitrous rat thyroid the TSP immunoreactivity was present after 1 week of treatment in the endothelial cells and most follicular cells, whilst stroma localisation was weak. After week 2 of treatment the endothelial cell and stromal localisation was no longer apparent, although a follicular localisation was still present. Transforming growth factor-beta 1 (TGF beta 1) immunoreactivity was present in the cytoplasm of a minority of the follicular cells in control rat thyroids, while their nuclei were unstained. In the goitrous rat thyroid an increase intensity of staining for TGF beta 1 was seen in all follicular cells, many of which now also demonstrated immuno-positive nuclei, within one week of goitrogen administration. These results show that in the hyperplastic thyroid increases in FGF-2 and TGF beta 1, and decreases in TSP1 accompany angiogenesis. These factors may interact in an autocrine/paracrine relationship to stimulate the neovascularisation that occurs during goitre formation.
Patel
V A
VA
Department of Medicine, University of Birmingham, Queen Elizabeth Hospital, Edgbaston, UK.
Hill
D J
DJ
Eggo
M C
MC
Sheppard
M C
MC
Becks
G P
GP
Logan
A
A
D000818:Animals; D015815:Cell Adhesion Molecules / Q000032:analysis / Q000378:metabolism*; D003593:Cytoplasm / Q000737:chemistry; D004727:Endothelium / Q000737:chemistry; D016222:Fibroblast Growth Factor 2 / Q000032:analysis / Q000378:metabolism; D006042:Goiter / Q000378:metabolism; D006133:Growth Substances / Q000032:analysis / Q000378:metabolism*; D006965:Hyperplasia; D007150:Immunohistochemistry; D008297:Male; D008562:Membrane Glycoproteins / Q000032:analysis / Q000378:metabolism*; D008713:Methimazole; D009389:Neovascularization, Pathologic / Q000378:metabolism*; D051381:Rats; D011919:Rats, Inbred Strains; D019699:Thrombospondins; D013961:Thyroid Gland / Q000737:chemistry / Q000378:metabolism / Q000473:pathology*; D016212:Transforming Growth Factor beta / Q000032:analysis / Q000378:metabolism
D015815:Cell Adhesion Molecules; D006133:Growth Substances; D008562:Membrane Glycoproteins; D019699:Thrombospondins; D016212:Transforming Growth Factor beta; D016222:Fibroblast Growth Factor 2; D008713:Methimazole